Geneos Wealth Management’s Curtiss-Wright CW Stock Holding History

Geneos Wealth Management’s Portfolio CW Stock Details CW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$5.51K	–	2492
2025 Q4	$5.51K	Buy	+10	New	+$5.58K	﹤0.01%	2113
2025 Q3	–	Sell	-42	Closed	-$20.5K	–	2652
2025 Q2	$20.5K	Buy	42 +2	+5%	+$789	﹤0.01%	2019
2025 Q1	$36.5K	Buy	40 +5	+14%	+$1.69K	﹤0.01%	2071
2024 Q4	$12.4K	Hold	35	–	–	﹤0.01%	1962
2024 Q3	$11.5K	Buy	+35	New	+$10.4K	﹤0.01%	1782
2020 Q4	–	Sell	-20	Closed	-$1K	–	2911
2020 Q3	$1K	Buy	+20	New	+$1.92K	﹤0.01%	2503
2018 Q2	–	Sell	-188	Closed	-$25K	–	2269
2018 Q1	$25K	Hold	188	–	–	﹤0.01%	1294
2017 Q4	$22K	Hold	188	–	–	﹤0.01%	1341
2017 Q3	$19K	Sell	188 -322	-63%	-$31.2K	﹤0.01%	1328
2017 Q2	$46K	Hold	510	–	–	﹤0.01%	948
2017 Q1	$46K	Hold	510	–	–	﹤0.01%	922
2016 Q4	$50K	Hold	510	–	–	0.01%	838
2016 Q3	$46K	Sell	510 -100	-16%	-$8.8K	0.01%	841
2016 Q2	$51K	Hold	610	–	–	0.01%	803
2016 Q1	$45K	Buy	+610	New	+$42.3K	0.01%	820

Other funds holding CW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geneos Wealth Management's CW Position: Q1 2026 in Review

Geneos Wealth Management sold out of Curtiss-Wright (CW) in Q1 2026, closing a stake of 10 shares — an estimated $5.51K sold.

Geneos Wealth Management first reported a position in CW in Q1 2016 and held it in 15 quarters. The position peaked at $51K in Q2 2016. 901 funds tracked by Wall St. Rank hold CW as of Q1 2026.

Geneos Wealth Management reported no remaining Curtiss-Wright position as of Q1 2026 after selling out during the quarter.
Geneos Wealth Management sold 10 Curtiss-Wright shares in Q1 2026, an estimated $5.51K.
Geneos Wealth Management first reported a position in Curtiss-Wright in Q1 2016 and held it in 15 quarters.
Geneos Wealth Management's Curtiss-Wright position peaked at $51K in Q2 2016.
901 funds tracked by Wall St. Rank held Curtiss-Wright as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.